Jonathan Barratt, MD, consultant nephrologist and professor of renal medicine, University of Leicester and John Walls Renal Unit, Leicester, provides a comprehensive overview of IgA nephropathy. Professor Barratt also discusses updates on new treatments for patients with IgA nephropathy.
Jennifer Vaughan, APRN, and Kenneth K. Afenya, MD, of Lex Kidney Care, Lexington, Kentucky, discuss the basics of IgA nephropathy, including signs and symptoms, as well as epidemiology…
Anand Reddy, MRCP (UK), FACP, FASN, Permian Regional Medical Center, Andrews, Texas; and Richard Lafayette, MD, FASN, professor of medicine and director of the Stanford Glomerular Disease Center,…
Jonathan Barratt, MD, University of Leicester, UK, discusses the need for improved continuity of care for patients with IgA nephropathy. Professor Barratt notes that the rarity of the…
Dana Rizk, MD, professor of medicine at the University of Alabama at Birmingham, discusses the approval of Fabhalta (iptacopan) for adults with IgA nephropathy. Iptacopan, a Factor B…
Explore IgA nephropathy, a rare autoimmune kidney disease where the IgA protein builds up in the kidneys. Normally, IgA helps protect against infections, but in this condition, it…
Sean Hashmi, MD, a board-certified nephrologist and obesity medicine specialist, for his weekly Friday night live sessions from Los Angeles. In this episode, Dr. Hashmi delves into IgA…
Delve into the importance of understanding IgA nephropathy, a condition that can lead to permanent kidney failure, requiring dialysis or transplantation. Patients with excessive protein loss in the…
Heather N. Reich, MD, CM, PhD, FRCPC, Oreopoulos-Baxter Division Director of Nephrology, University of Toronto, discusses translating new clinical trials in IgA nephropathy, a kidney disease. Dr Reich…
Dana V. Rizk, MD, professor of medicine, University of Alabama at Birmingham; and Gerald Appel, MD, professor of medicine and co-director of the Center for Glomerular Disease, Columbia…
Sean Converse was diagnosed with IgA nephropathy in late 2022 following an acute upper respiratory illness. Sean discusses challenges and his experience with IgA nephropathy.
